Niuminco EBITDA margin
Что обозначает EBITDA margin в Niuminco?
EBITDA margin Niuminco Group Limited является -383.18%
Какое определение для EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin компаний в Materials сектор на ASX по сравнению с Niuminco
Что делает Niuminco?
Niuminco Group Limited, through its subsidiaries, engages in the exploration and evaluation of mineral properties. The company primarily explores for gold, silver, and copper deposits. It holds a 100% interest in the May River and Bolobip exploration licenses; and the Edie Creek mining leases located in Papua New Guinea. The company was incorporated in 2006 and is based in Belrose, Australia.
Компании с ebitda margin похож на Niuminco
- Wrap Technologies имеет EBITDA margin из -387.37%
- Concurrent Computer имеет EBITDA margin из -384.81%
- CCUR имеет EBITDA margin из -384.81%
- Nagambie Resources имеет EBITDA margin из -384.51%
- OSE Immunotherapeutics SA имеет EBITDA margin из -383.51%
- Northern Minerals имеет EBITDA margin из -383.45%
- Niuminco имеет EBITDA margin из -383.18%
- INVO Bioscience имеет EBITDA margin из -383.06%
- Alterra имеет EBITDA margin из -382.96%
- Adamis Pharmaceuticals Corp имеет EBITDA margin из -382.23%
- Voluntis S.A имеет EBITDA margin из -379.54%
- Evgen Pharma plc имеет EBITDA margin из -379.12%
- American Resources имеет EBITDA margin из -378.54%